Background: Various reports have shown the efficacy of narrow-band UVB (311-313 nm) and excimer laser (308 nm) in the treatment of psoriasis. Objective: To prove the efficacy of light produced by xenon-chloride excimer at 308 nm (monochromatic excimer light, MEL) in the treatment of palmoplantar psoriasis (PP). Methods: Fifty-four patients (29 male and 25 female) affected by PP were treated with MEL every 7-14 days. A mean number of 10 sessions was performed with an increase of the dose depending on patient's skin type and response. Results: All 54 patients completed the treatment. After 4 months of MEL we observed a complete remission in 31 patients, a partial remission in 13 patients, and a moderate improvement in 10 patients. Conclusions: These results suggest that MEL can be considered as a valid therapeutic option for treatment of selected forms of PP
308nm monochromatic excimer light in the treatment of palmoplantar psoriasis / Nistico', S; Saraceno, R; Stefanescu, S; Chimenti, S. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - 20:5(2006), pp. 523-526. [10.1111/j.1468-3083.2006.01503.x]
308nm monochromatic excimer light in the treatment of palmoplantar psoriasis
NISTICO' S;
2006
Abstract
Background: Various reports have shown the efficacy of narrow-band UVB (311-313 nm) and excimer laser (308 nm) in the treatment of psoriasis. Objective: To prove the efficacy of light produced by xenon-chloride excimer at 308 nm (monochromatic excimer light, MEL) in the treatment of palmoplantar psoriasis (PP). Methods: Fifty-four patients (29 male and 25 female) affected by PP were treated with MEL every 7-14 days. A mean number of 10 sessions was performed with an increase of the dose depending on patient's skin type and response. Results: All 54 patients completed the treatment. After 4 months of MEL we observed a complete remission in 31 patients, a partial remission in 13 patients, and a moderate improvement in 10 patients. Conclusions: These results suggest that MEL can be considered as a valid therapeutic option for treatment of selected forms of PPFile | Dimensione | Formato | |
---|---|---|---|
Nisticò_308-NM_2006.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
96.08 kB
Formato
Adobe PDF
|
96.08 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.